Improved clinical outcomes with moisturization in dermatologic disease

Cutis

Volumn 76, Issue 6 SUPPL., 2005, Pages 13-18

  Ghali, Fred E ^a,b,c,d  

^a Pediatric Dermatology of North Texas   (United States)

^b Coria Laboratories Ltd ^*

^c Galderma Laboratories Inc ^*  (Spain)

^d Galderma Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; EMOLLIENT AGENT;

ATOPIC DERMATITIS; CHRONIC DISEASE; CONTROLLED CLINICAL TRIAL; HOSPITALIZATION; HUMAN; METHODOLOGY; PSORIASIS; REVIEW; SKIN ABSORPTION; SKIN CARE; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; CHRONIC DISEASE; CONTROLLED CLINICAL TRIALS; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; EMOLLIENTS; HUMANS; PSORIASIS; SEVERITY OF ILLNESS INDEX; SKIN ABSORPTION; SKIN CARE; TREATMENT OUTCOME;

EID: 30744445436     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Hanifin JM, Hebert AA, Mays SR, et al. Effects of a low-potency corticosteroid lotion plus a moisturizing regimen in the treatment of atopic dermatitis. Curr Ther Res Clin Exp. 1998;59:227-233.
2. Billmann-Eberwein C, Rippke F, Ruzicka T, et al. Modulation of atopy patch test reactions by topical treatment of human skin with a fatty acid-rich emollient. Skin Pharmacol Appl Skin Physiol. 2002;15:100-104.
3. Mahrle G, Wemmer U, Matthies C. Optimized interval treatment of eczema with fluprednidene. a multicenter double-blind study [in German]. Z Hautkr. 1989;64:766-768, 773-774.
4. Lucky AW, Leach AD, Laskarzewski P, et al. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol. 1997;14:321-324.
5. Watsky KL, Freije L, Leneveu MC, et al. Water-in-oil emollients as steroid-sparing adjunctive therapy in the treatment of psoriasis. Cutis. 1992;50:383-386.
6. Elias PM. Lipids and the epidermal water barrier: metabolism, regulation, and pathophysiology. Semin Dermatol. 1992;11:176-182.
7. Wertz PW. Lipids and barrier function of the skin. Acta Derm Venereol 2000;208(suppl):7-11.
8. Harding CR. The stratum corneum: structure and function in health and disease. Dermatol Ther. 2004;17:6-15.
9. Abe T, Ohkido M, Yamamoto K. Studies on skin surface barrier functions, skin surface lipids and transepidermal water loss in atopic skin during childhood. J Dermatol. 1978;5:223-229.
10. Melnick B, Hollmann J, Hofmann IJ, et al. Lipid composition of outer stratum comeum and nails in atopic and control subjects. Arch Dermatol Res. 1990;282:549-551.
11. Imokawa G, Abe A, Jin K, et al. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol. 1991;96:523-525.
12. Yamamoto A, Serizawa S, Ito M, et al. Stratum corneum lipid abnormalities in atopic dermatitis. Arch Dermatol Res. 1991;283:219-223.
13. Elias PM, Wood LC, Feingold KR. Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermat. 1999;10:119-126.
14. Elias PM, Feingold KR. Does the tail wag the dog? role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications. Arch Dermatol. 2001;137:1079-1081.
15. Shahidullah M, Raffle EJ, Rimmer AR, et al. Transepidermal water loss in patients with dermatitis. Br J Dermatol. 1969;81:722-730.
16. Werner Y, Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol. 1985;65:102-105.
17. Agner T. Noninvasive measuring methods for the investigation of irritant patch test reactions. a study of patients with hand eczema, atopic dermatitis and controls. Acta Derm Venereol. 1992;173(suppl):1-26.
18. Fartasch M, Diepgen TL. The barrier function in atopic dry skin disturbance of membrane-coating granule exocytosis and formation of epidermal lipids? Acta Derm Venereol. 1992;176:26-31.
19. Seidenari S, Giusti G. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol. 1995;75:429-433.
20. Aalto-Korte K. Improvement of skin barrier function during treatment of atopic dermatitis. J Am Acad Dermatol. 1995;33:969-972.
21. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh). 1980;92(suppl 92):44-47.
22. Berardesca E, Barbareschi M, Veraldi S, et al. Evaluation of efficacy of a skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis: a multicenter study. Contact Dermatitis. 2001;45:280-285.
23. Lebwohl M, Herrmann LG. Impaired skin barrier function in dermatologic disease and repair with moisturization. Cutis. 2005;76(suppl 6):7-12.
24. Hanifin J, Cooper KD, Ho VC, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Guidelines". J Am Acad Dermatol. 2004;50:391-404.
25. Ellis C, Luger T. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol. 2003;148(suppl 63):3-10.
26. Leung DY, Hanifin JM, Charlesworth EN, et al. Disease management of atopic dermatitis: a practice parameter. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Work Group on Atopic Dermatitis. Ann Allergy Asthma Immunol. 1997;79:197-211.
27. Eichenfield LF, Hanifin JM, Luger TA, et al. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol. 2003;49:1088-1095.
28. Drake LA, Ceilley RI, Cornelison RL, et al. Guidelines of care for psoriasis. J Am Acad Dermatol. 1993;28:632-637.
29. Callen JP, Krueger GG, Lebwohl M, et al. AAD consensus statement on psoriasis therapies. J Am Acad Dermatol. 2003;49:897-899.